| Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update M Omata, AL Cheng, N Kokudo, M Kudo, JM Lee, J Jia, R Tateishi, ... Hepatology international 11, 317-370, 2017 | 2139 | 2017 |
| Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma M Omata, LA Lesmana, R Tateishi, PJ Chen, SM Lin, H Yoshida, M Kudo, ... Hepatology international 4, 439-474, 2010 | 1250 | 2010 |
| A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma S Shiina, T Teratani, S Obi, S Sato, R Tateishi, T Fujishima, T Ishikawa, ... Gastroenterology 129 (1), 122-130, 2005 | 1049 | 2005 |
| Percutaneous radiofrequency ablation for hepatocellular carcinoma: an analysis of 1000 cases R Tateishi, S Shiina, T Teratani, S Obi, S Sato, Y Koike, T Fujishima, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2005 | 1036 | 2005 |
| Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors S Shiina, R Tateishi, T Arano, K Uchino, K Enooku, H Nakagawa, ... Official journal of the American College of Gastroenterology| ACG 107 (4 …, 2012 | 843 | 2012 |
| Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma N Fujiwara, H Nakagawa, Y Kudo, R Tateishi, M Taguri, T Watadani, ... Journal of hepatology 63 (1), 131-140, 2015 | 715 | 2015 |
| Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography R Masuzaki, R Tateishi, H Yoshida, E Goto, T Sato, T Ohki, J Imamura, ... Hepatology 49 (6), 1954-1961, 2009 | 524 | 2009 |
| Management of hepatocellular carcinoma in Japan: JSH consensus statements and recommendations 2021 update M Kudo, Y Kawamura, K Hasegawa, R Tateishi, K Kariyama, S Shiina, ... Liver cancer 10 (3), 181-223, 2021 | 517 | 2021 |
| Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling G He, D Dhar, H Nakagawa, J Font-Burgada, H Ogata, Y Jiang, ... Cell 155 (2), 384-396, 2013 | 508 | 2013 |
| Clinical practice guidelines for hepatocellular carcinoma: the Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update N Kokudo, N Takemura, K Hasegawa, T Takayama, S Kubo, M Shimada, ... Hepatology Research 49 (10), 1109-1113, 2019 | 498 | 2019 |
| Evidence‐based C linical P ractice G uidelines for H epatocellular C arcinoma: The J apan S ociety of H epatology 2013 update (3rd JSH‐HCC G uidelines) N Kokudo, K Hasegawa, M Akahane, H Igaki, N Izumi, T Ichida, S Uemoto, ... Hepatology Research 45 (2), 2015 | 484 | 2015 |
| Hepatocellular carcinoma with extrahepatic metastasis: clinical features and prognostic factors K Uchino, R Tateishi, S Shiina, M Kanda, R Masuzaki, Y Kondo, T Goto, ... Cancer 117 (19), 4475-4483, 2011 | 464 | 2011 |
| Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma V Kumar, N Kato, Y Urabe, A Takahashi, R Muroyama, N Hosono, ... Nature genetics 43 (5), 455-458, 2011 | 447 | 2011 |
| Radiofrequency ablation for hepatocellular carcinoma in so‐called high‐risk locations T Teratani, H Yoshida, S Shiina, S Obi, S Sato, R Tateishi, N Mine, ... Hepatology 43 (5), 1101-1108, 2006 | 396 | 2006 |
| Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients R Tateishi, H Yoshida, S Shiina, H Imamura, K Hasegawa, T Teratani, ... Gut 54 (3), 419-425, 2005 | 329 | 2005 |
| Combination therapy of intraarterial 5‐fluorouracil and systemic interferon‐alpha for advanced hepatocellular carcinoma with portal venous invasion S Obi, H Yoshida, R Toune, T Unuma, M Kanda, S Sato, R Tateishi, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2006 | 302 | 2006 |
| Treatment of hepatocellular carcinoma by percutaneous tumor ablation methods: ethanol injection therapy and radiofrequency ablation M Omata, R Tateishi, H Yoshida, S Shiina Gastroenterology 127 (5), S159-S166, 2004 | 276 | 2004 |
| APASL consensus statements and management algorithms for hepatitis C virus infection M Omata, T Kanda, ML Yu, O Yokosuka, SG Lim, W Jafri, R Tateishi, ... Hepatology International 6, 409-435, 2012 | 241 | 2012 |
| Diagnostic accuracy of tumor markers for hepatocellular carcinoma: a systematic review R Tateishi, H Yoshida, Y Matsuyama, N Mine, Y Kondo, M Omata Hepatology international 2, 17-30, 2008 | 234 | 2008 |
| Complications of percutaneous radiofrequency ablation for hepato-cellular carcinoma: imaging spectrum and management M Akahane, H Koga, N Kato, H Yamada, K Uozumi, R Tateishi, T Teratani, ... Radiographics 25 (suppl_1), S57-S68, 2005 | 227 | 2005 |
Kazuhiko KoikeThe University of Tokyo, Professor EmeritusCorreu electrònic verificat a umin.ac.jp
